Literature DB >> 7372781

Radioiodine as an adjunct to the surgical treatment of medullary thyroid carcinoma.

L J Deftos, M F Stein.   

Abstract

After total thyroidectomy for medullary thyroid carcinoma, a 50-yr-old male was found to have decreased but still abnormally elevated plasma calcitonin levels. A thyroid scan with 131I revealed remaining thyroid tissue primarily in the form of a thyroglossal duct remnant. Two courses of 131I treatment of 30 and 150 mCi, respectively, produced a gradual decrease in plasma calcitonin. This study demonstrates that carefully selected patients may benefit from the use of 131I treatment as an adjunct to surgery in medullary thyroid carcinoma.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7372781     DOI: 10.1210/jcem-50-5-967

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  4 in total

Review 1.  Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.

Authors:  Samuel A Wells; Sylvia L Asa; Henning Dralle; Rossella Elisei; Douglas B Evans; Robert F Gagel; Nancy Lee; Andreas Machens; Jeffrey F Moley; Furio Pacini; Friedhelm Raue; Karin Frank-Raue; Bruce Robinson; M Sara Rosenthal; Massimo Santoro; Martin Schlumberger; Manisha Shah; Steven G Waguespack
Journal:  Thyroid       Date:  2015-06       Impact factor: 6.568

2.  When is medullary thyroid carcinoma "medullary thyroid carcinoma"?

Authors:  G Riccabona; D Ladurner; K Schmid
Journal:  World J Surg       Date:  1986-10       Impact factor: 3.352

Review 3.  Medical management of metastatic medullary thyroid cancer.

Authors:  Jessica E Maxwell; Scott K Sherman; Thomas M O'Dorisio; James R Howe
Journal:  Cancer       Date:  2014-06-18       Impact factor: 6.860

4.  Utility of serum thyroglobulin measurements after prophylactic thyroidectomy in patients with hereditary medullary thyroid cancer.

Authors:  Carolyn D Seib; Avital Harari; Felix A Conte; Quan-Yang Duh; Orlo H Clark; Jessica E Gosnell
Journal:  Surgery       Date:  2014-06-02       Impact factor: 3.982

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.